Drug
Ruboxistaurin mesylate clinical trials
A product of Ruboxistaurin; its studies count on that page too.
How studies write it
Studies that test it under each name
Name
- Ruboxistaurin mesylate
- 3
By phase
A phase 1/2 study counts in both.
- Phase 3
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 0
Eli Lilly and Company (2) · Chromaderm, Inc. (1)
Related medicines
As reviewed, each with the page that says it.
- A salt or form of Ruboxistaurin
Studies
Open first, then newest update. How each study uses ruboxistaurin mesylate is read from its arms, and is right about nine times in ten.
Testing it · 3
- Treatment for Symptomatic Peripheral Neuropathy in Patients With DiabetesCompletedPhase 3Chromaderm, Inc.NCT00044408Written as Ruboxistaurin mesylate
- Treatment for Symptomatic Peripheral Neuropathy in Patients With DiabetesCompletedPhase 3Eli Lilly and CompanyNCT00044395Written as Ruboxistaurin mesylate
- Treatment of Peripheral Neuropathy in Patients With DiabetesCompletedPhase 3Eli Lilly and CompanyNCT00044421Written as Ruboxistaurin mesylate
Codes
What other systems call ruboxistaurin mesylate · ClinicalTrials.gg INT015328
- UNII (FDA) 6V860VW8AORUBOXISTAURIN MESYLATEConfirmed FDA, Wikidata
- Wikidata Q27265576ruboxistaurin mesylateConfirmed FDA, Wikidata
- NCI Thesaurus C218280Ruboxistaurin MesylateOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 6V860VW8AO | RUBOXISTAURIN MESYLATE | Confirmed FDA, Wikidata |
| Wikidata | Q27265576 | ruboxistaurin mesylate | Confirmed FDA, Wikidata |
| NCI Thesaurus | C218280 | Ruboxistaurin Mesylate | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.